SU2C-SITC Convergence Scholar Award 4

SU2C Convergence Research Team: Correlating Immunological Health to Cancer Susceptibility

sitc_log_color.png SU2C-10Year-Logo2.png

Team Leader

Mark Davis, PhD
Stanford University

Team Members

Stephen Quake, PhD
Stanford University
Thomas Montine, MD, PhD
Stanford University
Kari Nadeau, MD, PhD
Stanford University
David Furman, PhD
Stanford University

Project Summary

A preliminary analysis of over 450 adults showed that the immune response to influenza vaccine may be correlated with cancer susceptibility. In a small subset of elderly subjects who received the influenza vaccine, subjects with less robust immune response were more likely to develop and succumb to cancer. This team will correlate the varying immune cell (T- and B-cell populations) repertoires in individual patients with cancer susceptibility, comparing the results to a separate cohort of patients who are immune deficient. Even partial success could lead to testable signatures for cancer prediction.

Apply Now

To apply, send your CV, cover letter, and two letters of support to development@sitcancer.org. Please indicate the project to which you are applying.

Click here for more information regarding application requirements.

Applications due: Sept. 28, 2018

GENERAL INFORMATION

Details vary by project and institution, but the following applies to each opportunity
  • Full-time, multi-year commitment
  • Salary commensurate with experience and applicable policies
  • Fellowship will take place at either the Team Lead's institution or a partner institution
  • Additional eligibility criteria are determined by the Team Leads and host institutions